APO Research
Talk to an analyst

APO RESEARCH · REPORT

Functional Dyspepsia Drug

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.

Selected research

Market Structure

Global Functional Dyspepsia Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchFunctional Dyspepsia Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Functional Dyspepsia Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Functional Dyspepsia Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Functional Dyspepsia Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Functional Dyspepsia Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.

North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.

This report provides an overview of the global Functional Dyspepsia Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Functional Dyspepsia Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Functional Dyspepsia Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Functional Dyspepsia Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Functional Dyspepsia Drug Segment by Company

Bayer

Sumitomo

Cadila Pharmaceuticals

Teva

Johnson & Johnson

Pfizer

Sanofi

AstraZeneca

Jiangsu Aosaikang Pharma

Eisai

Kyowa Kirin Pharmaceuticals

Hanmi Pharm

Functional Dyspepsia Drug Segment by Type

Prokinetic Drugs

Gastric Antisecretory Drugs

Others

Functional Dyspepsia Drug Segment by Application

Hospitals

Drugstores

Functional Dyspepsia Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Functional Dyspepsia Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Functional Dyspepsia Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Functional Dyspepsia Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Functional Dyspepsia Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Functional Dyspepsia Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Functional Dyspepsia Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Functional Dyspepsia Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Functional Dyspepsia Drug Industry Trends Table 2. Functional Dyspepsia Drug Industry Drivers Table 3. Functional Dyspepsia Drug Industry Opportunities and Challenges Table 4. Functional Dyspepsia Drug Industry Restraints Table 5. Global Functional Dyspepsia Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Functional Dyspepsia Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Functional Dyspepsia Drug Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Functional Dyspepsia Drug Sales Market Share by Manufacturers Table 9. Global Functional Dyspepsia Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Functional Dyspepsia Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Functional Dyspepsia Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Functional Dyspepsia Drug Manufacturers, Product Type & Application Table 13. Global Functional Dyspepsia Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Functional Dyspepsia Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Prokinetic Drugs Table 17. Major Manufacturers of Gastric Antisecretory Drugs Table 18. Major Manufacturers of Others Table 19. Global Functional Dyspepsia Drug Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Functional Dyspepsia Drug Sales by Type (2021-2026) & (M Units) Table 21. Global Functional Dyspepsia Drug Sales by Type (2027-2032) & (M Units) Table 22. Global Functional Dyspepsia Drug Sales Market Share by Type (2021-2026) Table 23. Global Functional Dyspepsia Drug Sales Market Share by Type (2027-2032) Table 24. Global Functional Dyspepsia Drug Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 25. Global Functional Dyspepsia Drug Revenue by Type (2021-2026) & (M Units) Table 26. Global Functional Dyspepsia Drug Revenue by Type (2027-2032) & (M Units) Table 27. Global Functional Dyspepsia Drug Revenue Market Share by Type (2021-2026) Table 28. Global Functional Dyspepsia Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Drugstores Table 31. Global Functional Dyspepsia Drug Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 32. Global Functional Dyspepsia Drug Sales by Application (2021-2026) & (M Units) Table 33. Global Functional Dyspepsia Drug Sales by Application (2027-2032) & (M Units) Table 34. Global Functional Dyspepsia Drug Sales Market Share by Application (2021-2026) Table 35. Global Functional Dyspepsia Drug Sales Market Share by Application (2027-2032) Table 36. Global Functional Dyspepsia Drug Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 37. Global Functional Dyspepsia Drug Revenue by Application (2021-2026) & (M Units) Table 38. Global Functional Dyspepsia Drug Revenue by Application (2027-2032) & (M Units) Table 39. Global Functional Dyspepsia Drug Revenue Market Share by Application (2021-2026) Table 40. Global Functional Dyspepsia Drug Revenue Market Share by Application (2027-2032) Table 41. Global Functional Dyspepsia Drug Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 42. Global Functional Dyspepsia Drug Sales by Region (2021-2026) & (M Units) Table 43. Global Functional Dyspepsia Drug Sales Market Share by Region (2021-2026) Table 44. Global Functional Dyspepsia Drug Sales Forecasted by Region (2027-2032) & (M Units) Table 45. Global Functional Dyspepsia Drug Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Functional Dyspepsia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 47. North America Functional Dyspepsia Drug Sales by Country (2021-2026) & (M Units) Table 48. North America Functional Dyspepsia Drug Sales by Country (2027-2032) & (M Units) Table 49. Europe Functional Dyspepsia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 50. Europe Functional Dyspepsia Drug Sales by Country (2021-2026) & (M Units) Table 51. Europe Functional Dyspepsia Drug Sales by Country (2027-2032) & (M Units) Table 52. Asia Pacific Functional Dyspepsia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. Asia Pacific Functional Dyspepsia Drug Sales by Country (2021-2026) & (M Units) Table 54. Asia Pacific Functional Dyspepsia Drug Sales by Country (2027-2032) & (M Units) Table 55. South America, Middle East and Africa Functional Dyspepsia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. South America, Middle East and Africa Functional Dyspepsia Drug Sales by Country (2021-2026) & (M Units) Table 57. South America, Middle East and Africa Functional Dyspepsia Drug Sales by Country (2027-2032) & (M Units) Table 58. Global Functional Dyspepsia Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Functional Dyspepsia Drug Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Functional Dyspepsia Drug Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Functional Dyspepsia Drug Revenue Market Share by Region (2021-2026) Table 62. Global Functional Dyspepsia Drug Revenue Market Share by Region (2027-2032) Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bayer Functional Dyspepsia Drug Product Portfolio Table 67. Bayer Recent Development Table 68. Sumitomo Company Information Table 69. Sumitomo Business Overview Table 70. Sumitomo Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sumitomo Functional Dyspepsia Drug Product Portfolio Table 72. Sumitomo Recent Development Table 73. Cadila Pharmaceuticals Company Information Table 74. Cadila Pharmaceuticals Business Overview Table 75. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolio Table 77. Cadila Pharmaceuticals Recent Development Table 78. Teva Company Information Table 79. Teva Business Overview Table 80. Teva Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Teva Functional Dyspepsia Drug Product Portfolio Table 82. Teva Recent Development Table 83. Johnson & Johnson Company Information Table 84. Johnson & Johnson Business Overview Table 85. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Johnson & Johnson Functional Dyspepsia Drug Product Portfolio Table 87. Johnson & Johnson Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Pfizer Functional Dyspepsia Drug Product Portfolio Table 92. Pfizer Recent Development Table 93. Sanofi Company Information Table 94. Sanofi Business Overview Table 95. Sanofi Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sanofi Functional Dyspepsia Drug Product Portfolio Table 97. Sanofi Recent Development Table 98. AstraZeneca Company Information Table 99. AstraZeneca Business Overview Table 100. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. AstraZeneca Functional Dyspepsia Drug Product Portfolio Table 102. AstraZeneca Recent Development Table 103. Jiangsu Aosaikang Pharma Company Information Table 104. Jiangsu Aosaikang Pharma Business Overview Table 105. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolio Table 107. Jiangsu Aosaikang Pharma Recent Development Table 108. Eisai Company Information Table 109. Eisai Business Overview Table 110. Eisai Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Eisai Functional Dyspepsia Drug Product Portfolio Table 112. Eisai Recent Development Table 113. Kyowa Kirin Pharmaceuticals Company Information Table 114. Kyowa Kirin Pharmaceuticals Business Overview Table 115. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolio Table 117. Kyowa Kirin Pharmaceuticals Recent Development Table 118. Hanmi Pharm Company Information Table 119. Hanmi Pharm Business Overview Table 120. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Hanmi Pharm Functional Dyspepsia Drug Product Portfolio Table 122. Hanmi Pharm Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Functional Dyspepsia Drug Distributors List Table 126. Functional Dyspepsia Drug Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Functional Dyspepsia Drug Product Image Figure 2. Global Functional Dyspepsia Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Functional Dyspepsia Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Functional Dyspepsia Drug Sales (2021-2032) & (M Units) Figure 5. Global Functional Dyspepsia Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Functional Dyspepsia Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Prokinetic Drugs Image Figure 9. Gastric Antisecretory Drugs Image Figure 10. Others Image Figure 11. Global Functional Dyspepsia Drug Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Functional Dyspepsia Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Functional Dyspepsia Drug Sales Market Share by Type (2021-2032) Figure 14. Global Functional Dyspepsia Drug Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 15. Global Functional Dyspepsia Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Functional Dyspepsia Drug Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Drugstores Image Figure 19. Global Functional Dyspepsia Drug Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 20. Global Functional Dyspepsia Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Functional Dyspepsia Drug Sales Market Share by Application (2021-2032) Figure 22. Global Functional Dyspepsia Drug Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global Functional Dyspepsia Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Functional Dyspepsia Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 26. North America Functional Dyspepsia Drug Sales Market Share by Country (2021-2032) Figure 27. U.S. Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 28. Canada Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 29. Mexico Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Europe Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Europe Functional Dyspepsia Drug Sales Market Share by Country (2021-2032) Figure 32. Germany Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 33. France Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 34. U.K. Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Italy Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Netherlands Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Asia Pacific Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Asia Pacific Functional Dyspepsia Drug Sales Market Share by Country (2021-2032) Figure 39. China Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Japan Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 41. South Korea Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Southeast Asia Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 43. India Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Australia Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 45. South America, Middle East and Africa Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 46. South America, Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Country (2021-2032) Figure 47. Brazil Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South Africa Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 49. Saudi Arabia Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Turkey Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Argentina Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 52. UAE Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Egypt Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Chile Functional Dyspepsia Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Global Functional Dyspepsia Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Functional Dyspepsia Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Functional Dyspepsia Drug Revenue (2021-2032) & (US$ Million) Figure 58. North America Functional Dyspepsia Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Functional Dyspepsia Drug Revenue (2021-2032) & (US$ Million) Figure 60. Europe Functional Dyspepsia Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Functional Dyspepsia Drug Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Functional Dyspepsia Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Functional Dyspepsia Drug Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Functional Dyspepsia Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Functional Dyspepsia Drug Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Functional Dyspepsia Drug Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Prokinetic Drugs
  • Gastric Antisecretory Drugs
  • Others
Applications
  • Hospitals
  • Drugstores
Companies covered
  • Bayer
  • Sumitomo
  • Cadila Pharmaceuticals
  • Teva
  • Johnson & Johnson
  • Pfizer
  • Sanofi
  • AstraZeneca
  • Jiangsu Aosaikang Pharma
  • Eisai
  • Kyowa Kirin Pharmaceuticals
  • Hanmi Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Functional Dyspepsia Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Functional Dyspepsia Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Functional Dyspepsia Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Functional Dyspepsia Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Functional Dyspepsia Drug Market Dynamics
  1. 2.1 Functional Dyspepsia Drug Industry Trends
  2. 2.2 Functional Dyspepsia Drug Industry Drivers
  3. 2.3 Functional Dyspepsia Drug Industry Opportunities and Challenges
  4. 2.4 Functional Dyspepsia Drug Industry Restraints
3 Functional Dyspepsia Drug Market by Manufacturers
  1. 3.1 Global Functional Dyspepsia Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Functional Dyspepsia Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Functional Dyspepsia Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Functional Dyspepsia Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Functional Dyspepsia Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Functional Dyspepsia Drug Manufacturers, Product Type & Application
  7. 3.7 Global Functional Dyspepsia Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Functional Dyspepsia Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Functional Dyspepsia Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Functional Dyspepsia Drug Tier 1, Tier 2, and Tier 3
4 Functional Dyspepsia Drug Market by Type
  1. 4.1 Functional Dyspepsia Drug Type Introduction
  2. 4.1.1 Prokinetic Drugs
  3. 4.1.2 Gastric Antisecretory Drugs
  4. 4.1.3 Others
  5. 4.2 Global Functional Dyspepsia Drug Sales by Type
  6. 4.2.1 Global Functional Dyspepsia Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Functional Dyspepsia Drug Sales by Type (2021-2032)
  8. 4.2.3 Global Functional Dyspepsia Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global Functional Dyspepsia Drug Revenue by Type
  10. 4.3.1 Global Functional Dyspepsia Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Functional Dyspepsia Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global Functional Dyspepsia Drug Revenue Market Share by Type (2021-2032)
5 Functional Dyspepsia Drug Market by Application
  1. 5.1 Functional Dyspepsia Drug Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Drugstores
  4. 5.2 Global Functional Dyspepsia Drug Sales by Application
  5. 5.2.1 Global Functional Dyspepsia Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Functional Dyspepsia Drug Sales by Application (2021-2032)
  7. 5.2.3 Global Functional Dyspepsia Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global Functional Dyspepsia Drug Revenue by Application
  9. 5.3.1 Global Functional Dyspepsia Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Functional Dyspepsia Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global Functional Dyspepsia Drug Revenue Market Share by Application (2021-2032)
6 Global Functional Dyspepsia Drug Sales by Region
  1. 6.1 Global Functional Dyspepsia Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Functional Dyspepsia Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Functional Dyspepsia Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Functional Dyspepsia Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Functional Dyspepsia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Functional Dyspepsia Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Functional Dyspepsia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Functional Dyspepsia Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Functional Dyspepsia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Functional Dyspepsia Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Functional Dyspepsia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Functional Dyspepsia Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Functional Dyspepsia Drug Revenue by Region
  1. 7.1 Global Functional Dyspepsia Drug Revenue by Region
  2. 7.1.1 Global Functional Dyspepsia Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Functional Dyspepsia Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Functional Dyspepsia Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Functional Dyspepsia Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Functional Dyspepsia Drug Revenue (2021-2032)
  8. 7.2.2 North America Functional Dyspepsia Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Functional Dyspepsia Drug Revenue (2021-2032)
  11. 7.3.2 Europe Functional Dyspepsia Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Functional Dyspepsia Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Functional Dyspepsia Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Functional Dyspepsia Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Functional Dyspepsia Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bayer Functional Dyspepsia Drug Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 Sumitomo
  8. 8.2.1 Sumitomo Company Information
  9. 8.2.2 Sumitomo Business Overview
  10. 8.2.3 Sumitomo Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sumitomo Functional Dyspepsia Drug Product Portfolio
  12. 8.2.5 Sumitomo Recent Developments
  13. 8.3 Cadila Pharmaceuticals
  14. 8.3.1 Cadila Pharmaceuticals Company Information
  15. 8.3.2 Cadila Pharmaceuticals Business Overview
  16. 8.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
  18. 8.3.5 Cadila Pharmaceuticals Recent Developments
  19. 8.4 Teva
  20. 8.4.1 Teva Company Information
  21. 8.4.2 Teva Business Overview
  22. 8.4.3 Teva Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Teva Functional Dyspepsia Drug Product Portfolio
  24. 8.4.5 Teva Recent Developments
  25. 8.5 Johnson & Johnson
  26. 8.5.1 Johnson & Johnson Company Information
  27. 8.5.2 Johnson & Johnson Business Overview
  28. 8.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Johnson & Johnson Functional Dyspepsia Drug Product Portfolio
  30. 8.5.5 Johnson & Johnson Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Functional Dyspepsia Drug Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Sanofi
  38. 8.7.1 Sanofi Company Information
  39. 8.7.2 Sanofi Business Overview
  40. 8.7.3 Sanofi Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Functional Dyspepsia Drug Product Portfolio
  42. 8.7.5 Sanofi Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca Functional Dyspepsia Drug Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Jiangsu Aosaikang Pharma
  50. 8.9.1 Jiangsu Aosaikang Pharma Company Information
  51. 8.9.2 Jiangsu Aosaikang Pharma Business Overview
  52. 8.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolio
  54. 8.9.5 Jiangsu Aosaikang Pharma Recent Developments
  55. 8.10 Eisai
  56. 8.10.1 Eisai Company Information
  57. 8.10.2 Eisai Business Overview
  58. 8.10.3 Eisai Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Eisai Functional Dyspepsia Drug Product Portfolio
  60. 8.10.5 Eisai Recent Developments
  61. 8.11 Kyowa Kirin Pharmaceuticals
  62. 8.11.1 Kyowa Kirin Pharmaceuticals Company Information
  63. 8.11.2 Kyowa Kirin Pharmaceuticals Business Overview
  64. 8.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
  66. 8.11.5 Kyowa Kirin Pharmaceuticals Recent Developments
  67. 8.12 Hanmi Pharm
  68. 8.12.1 Hanmi Pharm Company Information
  69. 8.12.2 Hanmi Pharm Business Overview
  70. 8.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hanmi Pharm Functional Dyspepsia Drug Product Portfolio
  72. 8.12.5 Hanmi Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Functional Dyspepsia Drug Value Chain Analysis
  2. 9.1.1 Functional Dyspepsia Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Functional Dyspepsia Drug Production Mode & Process
  6. 9.2 Functional Dyspepsia Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Functional Dyspepsia Drug Distributors
  9. 9.2.3 Functional Dyspepsia Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst